Center for Metabolic and Vascular Biology

The mission of the Center for Metabolic and Vascular Biology (CMVB) is to create, apply, and disseminate new knowledge of the mechanisms responsible for the development of type 2 diabetes and cardiovascular disease.

In partnership with the Mayo Clinic, Scottsdale, the center brings together basic scientists with physician investigators to study inflammatory processes, insulin signaling, mitochondrial and vascular biology, gene expression regulation and adipocyte biology. Through collaborative efforts, the center strives to not only discover the mechanisms involved in the development of diabetes and cardiovascular disease, but to extend that knowledge to the bedside and the community in order to improve the lives of countless people.

The center features a clinical research unit (CRU) developed by Director Lawrence Mandarino, who is also a professor in ASU's School of Life Sciences. The clinical unit has the capability to perform patient-oriented research studies ranging from basic physiological measurements to invasive metabolic procedures. The primary focus of research performed through the unit is type 2 diabetes; additional services are extended to research faculty across all ASU campuses.